PE20030292A1 - Compuestos de heteroarilo biciclicos fusionados substituidos con heteroarilo como ligandos del receptor gabaa - Google Patents

Compuestos de heteroarilo biciclicos fusionados substituidos con heteroarilo como ligandos del receptor gabaa

Info

Publication number
PE20030292A1
PE20030292A1 PE2002000626A PE2002000626A PE20030292A1 PE 20030292 A1 PE20030292 A1 PE 20030292A1 PE 2002000626 A PE2002000626 A PE 2002000626A PE 2002000626 A PE2002000626 A PE 2002000626A PE 20030292 A1 PE20030292 A1 PE 20030292A1
Authority
PE
Peru
Prior art keywords
heteroaryl
alkyl
compounds
gabaa
imidazol
Prior art date
Application number
PE2002000626A
Other languages
English (en)
Inventor
Alan Hutchinson
George Maynard
Linghong Xie
Scott Mitchell
Manuka Ghosh
Nian Liu
Kevin Currie
Guiying Li
Vinod Singh
Jun Yuan
Pamela Albaugh
Original Assignee
Neurogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corp filed Critical Neurogen Corp
Publication of PE20030292A1 publication Critical patent/PE20030292A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Abstract

SE REFIERE A UN COMPUESTOS DE HETEROARILO BICICLICOS FUSIONADOS SUBSTITUIDOS CON HETEROARILO DE FORMULA I DONDE Z1 ES N, CR1; Z2 ES N, CR2; Z3 ES N, CR3; Z4 ES N, CR4; Z5 ES N, C; Z6 ES N, C SIEMPRE QUE NO MAS DE DOS Z1-Z6 SEAN N; R1-R4 SON H, HALOGENO, HIDROXI, NITRO, CIANO, AMINO, ENTRE OTROS, ALQUILO, ALCOXI, CICLOALQUILO, ALQUENILO ENTRE OTROS; R5 ES H, HALOGENO, CIANO, HALOALQUILO O R5 REPRESENTA ALQUILO, CICLOALQUILO, ARILO, ARILALQUILO, HETEROARILO, ENTRE OTROS; Q ES -C(R6)(R7), -N(ALQUILO)-, O, CON LA CONDICION DE QUE Q NO SEA O CUANDO X2 ES N; R6 Y R7 ES H, F, ALQUILO; Y ES N, C, -CH-, -CH2-; W ES ARILO, HETEROARILO. SON COMPUESTOS PREFERIDOS 6-CLORO-2-[(2-FENIL-1H-IMIDAZOL-1-IL)METIL]-3-PROPILIMIDAZO[1,2-a]PIRIDINA, 6-CLORO-2-{[2-(3-FLUOROFENIL)-1H-IMIDAZOL-1-IL]METIL}IMIDAZO[1,2-a]PIRIDINA, 6-CLORO-2-{[2-(3-CLOROFENIL)-1H-IMIDAZOL-1-IL]METIL}IMIDAZO[1,2-a]PIRIDINA, ENTRE OTROS. SE REFIERE TAMBIEN A COMPUESTOS DE HETEROARILO BICICLICOS TAL COMO IMIDAZOPIRIDINAS, IMIDAZOPIRAZINAS, IMIDAZOPIRIDAZINAS , IMIDAZOPIRIMIDINAS E IMIDAZOTIAZOLES SUBSTITUIDOS CON HETEROARILO Y DE MANERA MAS ESPECIFICA CON LOS COMPUESTOS QUE SE ENLAZAN CON ELEVADA SELECTIVIDAD Y ELEVADA AFINIDAD CON LOS LUGARES DE BENZODIAZEPINA DE LOS RECEPTORES GABAA UTIL PARA EL TRATAMIENTO DE ENFERMEDADES DEL SISTEMA NERVIOSO CENTRAL
PE2002000626A 2001-07-13 2002-07-12 Compuestos de heteroarilo biciclicos fusionados substituidos con heteroarilo como ligandos del receptor gabaa PE20030292A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30553301P 2001-07-13 2001-07-13

Publications (1)

Publication Number Publication Date
PE20030292A1 true PE20030292A1 (es) 2003-04-03

Family

ID=23181185

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002000626A PE20030292A1 (es) 2001-07-13 2002-07-12 Compuestos de heteroarilo biciclicos fusionados substituidos con heteroarilo como ligandos del receptor gabaa

Country Status (16)

Country Link
US (2) US6936617B2 (es)
EP (1) EP1406906A1 (es)
JP (1) JP2005505518A (es)
KR (1) KR20040015356A (es)
CN (2) CN101220027A (es)
AR (1) AR036168A1 (es)
BR (1) BR0211124A (es)
CA (1) CA2453554A1 (es)
GT (1) GT200200148A (es)
IL (1) IL159811A0 (es)
MX (1) MXPA04000372A (es)
NZ (1) NZ530992A (es)
PA (1) PA8550401A1 (es)
PE (1) PE20030292A1 (es)
UY (1) UY27380A1 (es)
WO (1) WO2003006471A1 (es)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7482366B2 (en) * 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
MXPA04011472A (es) 2002-05-22 2005-02-14 Amgen Inc Derivados de amino-piridina, piridina y piridazina para usarse como ligandos del receptor vaniloide para el tratamiento del dolor.
WO2004014871A1 (en) 2002-08-08 2004-02-19 Amgen Inc. Vanilloid receptor ligands and their use in treatments
UA80295C2 (en) 2002-09-06 2007-09-10 Biogen Inc Pyrazolopyridines and using the same
DE10247271A1 (de) * 2002-10-10 2004-08-26 Grünenthal GmbH Substituierte C-Imidazo[1,2-a]pyridin-3-yle
CN100457756C (zh) * 2003-07-25 2009-02-04 神经能质公司 咪唑-嘧啶类及三唑-嘧啶类:苯并二氮平受体配体
WO2005012306A2 (en) 2003-07-25 2005-02-10 Neurogen Corporation Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands
EP1880998A1 (en) * 2003-07-25 2008-01-23 Neurogen Corporation Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands
US7534798B2 (en) 2004-02-11 2009-05-19 Amgen Inc. Vanilloid receptor ligands and their use in treatments
MY139645A (en) 2004-02-11 2009-10-30 Amgen Inc Vanilloid receptor ligands and their use in treatments
US20090023737A1 (en) * 2004-02-12 2009-01-22 Neurogen Corporation Imidazo-Pyridazines, Triazolo-Pyridazines and Related Benzodiazepine Receptor Ligands
WO2006052546A2 (en) * 2004-11-04 2006-05-18 Neurogen Corporation Pyrazolylmethyl heteroaryl derivatives
WO2006089311A1 (en) 2005-02-15 2006-08-24 Amgen Inc. Vanilloid receptor ligands and their use in treatments
US20070155738A1 (en) 2005-05-20 2007-07-05 Alantos Pharmaceuticals, Inc. Heterobicyclic metalloprotease inhibitors
TW200800213A (en) 2005-09-02 2008-01-01 Abbott Lab Novel imidazo based heterocycles
US7750000B2 (en) * 2005-09-02 2010-07-06 Bayer Schering Pharma Ag Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments
MX2008008152A (es) * 2005-12-23 2008-09-12 Ariad Pharma Inc Compuestos heterociclicos biciclicos.
BRPI0710328A2 (pt) * 2006-05-08 2011-08-09 Ariad Pharma Inc composto da fórmula i, um tautomer da mesma, ou um sal farmaceuticamente aceitável, hidrato ou outro solvato do mesmo e método para o tratamento de cáncer em um mamìfero necessitado do mesmo e composição
KR101441365B1 (ko) * 2006-05-08 2014-09-18 어리어드 파마슈티칼스, 인코포레이티드 모노시클릭 헤테로아릴 화합물
US20080249305A1 (en) * 2007-03-27 2008-10-09 Calderwood David J Novel imidazole based heterocycles
EP1974729A1 (en) 2007-03-28 2008-10-01 Santhera Pharmaceuticals (Schweiz) AG Substituted imidazopyridine derivates as melanocortin- 4 receptor antagonists
EP2072516A1 (en) * 2007-12-21 2009-06-24 Santhera Pharmaceuticals (Schweiz) AG Substituted imidazopyridine derivates as Melancortin-4 receptor antagonists
US8263630B2 (en) 2008-02-12 2012-09-11 Bristol-Myers Squibb Company 1,2,3-triazoles as 11-beta hydroxysteroid dehydrogenase type I inhibitors
EP2365809B8 (en) 2008-11-12 2018-10-10 Ariad Pharmaceuticals, Inc. Pyrazinopyrazines and derivatives as kinase inhibitors
US10206921B2 (en) 2009-06-03 2019-02-19 The Regents Of The University Of California Methods and compositions for treating a subject for central nervous system (CNS) injury
EP2298296A1 (en) * 2009-08-25 2011-03-23 CNRS Centre National De La Recherche Scientifique Composition and method for treating cognitive impairments in down syndrome subjects
MX2012004990A (es) 2009-10-30 2012-06-12 Janssen Pharmaceutica Nv Deribados de imidazo [1,2-b] pirimideazina y su uso como inhibidores de la enzima fosfodiesterasa 10.
AR080754A1 (es) 2010-03-09 2012-05-09 Janssen Pharmaceutica Nv Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
US20130150351A1 (en) * 2010-06-03 2013-06-13 Stanley T. Carmichael Methods and compositions for treating a subject for central nervous system (cns) injury
KR101034040B1 (ko) * 2010-08-16 2011-05-16 정동영 백업트랙터
BR112013033375B1 (pt) 2011-06-27 2022-05-10 Janssen Pharmaceutica N.V Derivados de 1-aril-4-metil-[1,2,4]triazolo[4,3-a]quinoxa-lina, seu uso, composição farmacêutica que os compreende, processo de preparação dos mesmos, solução estéril e composto intermediário
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
CN104411312B (zh) 2012-06-26 2018-03-06 詹森药业有限公司 包括pde2抑制剂例如1‑芳基‑4‑甲基‑[1,2,4]三唑[4,3‑a]‑喹喔啉化合物和pde10抑制剂的用于在治疗神经病学障碍或代谢障碍中使用的组合
MX362197B (es) 2012-07-09 2019-01-08 Janssen Pharmaceutica Nv Derivados de imidazo[1,2-b]piridazina e imidazo[1,2-a]pirazina como inhibidores de la fosfodiesterasa 10; y el uso de los mismos en el tratamiento de trastornos neurológicos, psiquiátricos y metabólicos.
CA3167093A1 (en) 2012-12-12 2014-06-12 Ariad Pharmaceuticals, Inc. Crystalline form c of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl}benzamide mono hydrochloride
US9527835B2 (en) 2014-02-13 2016-12-27 Incyte Corporation Cyclopropylamines as LSD1 inhibitors
ES2672797T3 (es) 2014-02-13 2018-06-18 Incyte Corporation Ciclopropilaminas como inhibidores de LSD1
ME03580B (me) 2014-02-13 2020-07-20 Incyte Corp Ciklopropilamini kao lsd1 inhibitori
CA2939082C (en) 2014-02-13 2022-06-07 Incyte Corporation Cyclopropylamines as lsd1 inhibitors
WO2016007731A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Imidazopyridines and imidazopyrazines as lsd1 inhibitors
WO2016007722A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
TW201613925A (en) 2014-07-10 2016-04-16 Incyte Corp Imidazopyrazines as LSD1 inhibitors
WO2016007727A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
AU2015374118B2 (en) 2014-12-29 2020-07-23 The Trustees Of The University Of Pennsylvania Small molecule inhibitors of lactate dehydrogenase and methods of use thereof
TWI714567B (zh) 2015-04-03 2021-01-01 美商英塞特公司 作為lsd1抑制劑之雜環化合物
CR20180152A (es) 2015-08-12 2018-08-09 Incyte Corp Sales de un inhibidor de lsd1
MX2018012901A (es) 2016-04-22 2019-06-06 Incyte Corp Formulaciones de inhibidor de demetilasa 1 especifica para lisina (lsd1).
WO2020047198A1 (en) 2018-08-31 2020-03-05 Incyte Corporation Salts of an lsd1 inhibitor and processes for preparing the same
WO2020113094A1 (en) 2018-11-30 2020-06-04 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
CN111662270A (zh) * 2019-03-05 2020-09-15 中国医学科学院药物研究所 碘同位素标记苄苯醚衍生物、及其制法和药物组合物与用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001333A1 (en) * 1987-08-07 1989-02-23 The Australian National University IMIDAZO[1,2-b]PYRIDAZINES
WO1996034866A1 (en) * 1995-05-01 1996-11-07 Fujisawa Pharmaceutical Co., Ltd. Imidazo 1,2-a pyridine and imidazo 1,2-a pyridezine derivatives and their use as bone resorption inhibitors
GB9801538D0 (en) 1998-01-23 1998-03-25 Merck Sharp & Dohme Pharmaceutical product
GB9805561D0 (en) 1998-03-16 1998-05-13 Merck Sharp & Dohme A combination of therapeutic agents
GB9805559D0 (en) 1998-03-16 1998-05-13 Merck Sharp & Dohme A combination of therapeutic agents
GB9805557D0 (en) 1998-03-16 1998-05-13 Merck Sharp & Dohme A combination of therapeutic agents
US6271241B1 (en) 1999-04-02 2001-08-07 Neurogen Corporation Cycloalkyl and aryl fused aminoalkyl-imidazole derivatives: modulators and GLP-1 receptors
US6380210B1 (en) 1999-04-02 2002-04-30 Neurogen Corporation Heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors
US6358949B1 (en) 1999-04-02 2002-03-19 Neurogen Corporation Aryl and hetroaryl fused aminoalkyl-imidazole derivatives: selective modulators of bradykinin B2 receptors
AU2001236471A1 (en) 2000-01-18 2001-07-31 Neurogen Corporation Imidazopyridines and related azacyclic derivatives as selective modulators of bradykinin b2 receptors
AU2001270297A1 (en) * 2000-06-30 2002-01-14 Neurogen Corporation 2-phenylimidazo(1,2-a)pyridine derivatives: a new class of gaba brain receptor ligands
PA8535601A1 (es) 2000-12-21 2002-11-28 Pfizer Derivados benzimidazol y piridilimidazol como ligandos para gabaa

Also Published As

Publication number Publication date
KR20040015356A (ko) 2004-02-18
PA8550401A1 (es) 2004-02-07
EP1406906A1 (en) 2004-04-14
IL159811A0 (en) 2004-06-20
US20030207885A1 (en) 2003-11-06
CN101220027A (zh) 2008-07-16
AR036168A1 (es) 2004-08-18
US6936617B2 (en) 2005-08-30
CN1553916A (zh) 2004-12-08
NZ530992A (en) 2005-06-24
GT200200148A (es) 2003-05-15
JP2005505518A (ja) 2005-02-24
US20060014746A1 (en) 2006-01-19
BR0211124A (pt) 2004-06-29
MXPA04000372A (es) 2004-07-23
CN100369912C (zh) 2008-02-20
CA2453554A1 (en) 2003-01-23
UY27380A1 (es) 2003-02-28
WO2003006471A1 (en) 2003-01-23

Similar Documents

Publication Publication Date Title
PE20030292A1 (es) Compuestos de heteroarilo biciclicos fusionados substituidos con heteroarilo como ligandos del receptor gabaa
Couty et al. Synthesis of 3-(arylmethylene) isoindolin-1-ones from ynamides by Heck–Suzuki–Miyaura domino reactions. Application to the synthesis of lennoxamine
PE20020911A1 (es) Derivados de indol como agonistas de 5ht2
PE20040593A1 (es) DERIVADOS DE DIHIDROPIRIMIDO[4,5-d]PIRIMIDONA AMINO SUSTITUIDOS COMO INHIBIDORES DE TIROSINACINASAS DEL GRUPO SRC
PE20010629A1 (es) Derivados de triazolpiridinamina como ligandos de receptores de adenosina
PE20020720A1 (es) Derivados benzimidazol y piridilimidazol como ligandos para receptores gabaa
AR004320A1 (es) Nuevos compuestos de pirimidina condensados biciclicos; un procedimiento para su preparacion; composiciones farmaceuticas que los contienen y su usocomo agentes terapeuticos, en particular como inhibidores de la tirosina quinasa.
PE20030845A1 (es) Compuestos de espiro-hidantoina utiles como agentes anti-inflamatorios
WO2001034603A3 (en) Bicyclic and tricyclic heteroaromatic compounds
PE20011305A1 (es) Agentes diazabiciclicos activos en el snc
PE20030922A1 (es) Derivados de piridina y quinolina
PE91198A1 (es) DERIVADOS PIRIDO[3,4-d]PIRIMIDINA
PE20030155A1 (es) Azaindoles como inhibidores de quinasas
PE20050465A1 (es) Compuestos derivados de quinuclidina como antagonistas del receptor muscarinico m3
OA10977A (en) Substituted 6,5-hetero-bicyclic derivatives
PE20000467A1 (es) Derivado de indol util como inhibidor de serotonina
PE20011084A1 (es) Derivados de quinolina como antagonistas alfa-2
Sun et al. FeCl3-catalyzed cascade cyclization in one pot: synthesis of ring-fused tetrahydroquinoline derivatives from arylamines and N-substituted lactams
ES2154470T3 (es) Derivados de tetrahidroisoquinolina y su uso farmaceutico.
PE20020970A1 (es) Derivados de imidazo-pirimidina como ligandos para los receptores de gaba
Oshiyama et al. Total synthesis of makaluvamine A/D, damirone B, batzelline C, makaluvone, and isobatzelline C featuring one-pot benzyne-mediated cyclization–functionalization
Strödke et al. Synthesis of Desaza Analogues of Annomontine and Canthin‐4‐one Alkaloids
GT200500319A (es) Algunos metabolitos derivados de [1,4]diazepino[6,7,1-ij]quinolina y metodos para la preparacion y usos de los mismos.
Jen et al. Amidines. 5. Synthesis of pyrrolo [2, 3,-b] isoquinoline imidazo [1, 2-b] isoquinoline, pyrrolo [2, 1-b] quinazoline, and 1, 3-thiazino [2, 3-b] quinazoline derivatives and related heterocycles as potential antihypertensive agents
PE20010481A1 (es) Derivados de la octahidro-1h-pirido[1,2-a]pirazina 2,7-sustituida como ligandos para receptores de la serotonina

Legal Events

Date Code Title Description
FA Abandonment or withdrawal